Literature DB >> 9342755

Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix.

B Davidson1, I Goldberg, J Kopolovic.   

Abstract

Leukocytic infiltrates are a morphologic feature of most solid tumors, including uterine cervical intraepithelial neoplasia (CIN) and invasive carcinoma. We have studied 50 cases of CIN I, CIN II, CIN III, invasive carcinoma and normal controls in order to evaluate the inflammatory response. Two markers--CD68, a macrophage-specific marker, and ICAM-1, present on leukocytes, blood vessels and epithelial cells--were employed. Results have demonstrated similar inflammatory cell counts in normal, CIN II and CIN III lesions by both markers, and lower counts for CIN I. Invasive carcinomas demonstrated a statistically significant increase in infiltrate density by both CD68 (p < 0.002) and ICAM-1 (p < 0.05). Macrophage density by either marker did not correlate with Human Papillomavirus (HPV) presence, specific type, or evidence of co-infection with several types. We conclude that the inflammatory response to cervical intraepithelial-neoplasia is inadequate. The elevated cell counts in invasive carcinomas may reflect a reaction towards invasion rather than tumor-specific immune response. Depression of inflammation in CIN I lesions may be associated with active viral replication in these lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342755     DOI: 10.1016/s0344-0338(97)80102-1

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Authors:  Mark E Scott; Yurii B Shvetsov; Pamela J Thompson; Brenda Y Hernandez; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Dien D Vo; Anna-Barbara Moscicki; Marc T Goodman
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

2.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Authors:  Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

3.  Tumor-Associated CD163+ M2 Macrophage Infiltration is Highly Associated with PD-L1 Expression in Cervical Cancer.

Authors:  Fan Guo; Yang-Chun Feng; Gang Zhao; Ran Zhang; Zhen-Zhen Cheng; Wei-Na Kong; Hui-Li Wu; Bin Xu; Xiang Lv; Xiu-Min Ma
Journal:  Cancer Manag Res       Date:  2020-07-15       Impact factor: 3.989

Review 4.  Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.

Authors:  Locke D Uppendahl; Carly M Dahl; Jeffrey S Miller; Martin Felices; Melissa A Geller
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

5.  Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients.

Authors:  Qun Wang; Elisa Schmoeckel; Bernd P Kost; Christina Kuhn; Aurelia Vattai; Theresa Vilsmaier; Sven Mahner; Doris Mayr; Udo Jeschke; Helene Hildegard Heidegger
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

6.  Alcohol consumption and viral load are synergistically associated with CIN1.

Authors:  Kyung-Jin Min; Jae-Kwan Lee; Sanghoon Lee; Mi Kyung Kim
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

Review 7.  Targeting of activated fibroblasts for imaging and therapy.

Authors:  Thomas Lindner; Anastasia Loktev; Frederik Giesel; Clemens Kratochwil; Annette Altmann; Uwe Haberkorn
Journal:  EJNMMI Radiopharm Chem       Date:  2019-07-25

8.  High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis.

Authors:  Sangjeong Ahn; Gi Jeong Kim; Sung-Im Do; Kyungeun Kim; Hyunjoo Lee; In-Gu Do; Dong-Hoon Kim; Seoung Wan Chae; Seungho Ryu; Jin Hee Sohn
Journal:  J Epidemiol       Date:  2021-02-02       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.